企業プロフィール
Surrozen 株価・ニュース・カタリスト
- ティッカー:
- SRZN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
23.99 USD (+2.09%)
終値
最終更新: 2026年8月21日
269M USD
時価総額
株価変動の要因
As of Aug 21, 2026, SRZN closed up 2.09% at $23.99. No new same-company headline was identified in the current news window.
企業概要
事業概要
Surrozen is a biotechnology company focused on tissue regeneration and organ repair through Wnt biology. Its story centers on whether developmental biology can be translated into therapies for difficult diseases.
所在地とセクター分類
Surrozen is headquartered in the United States and listed on NASDAQ. It sits in the regenerative and platform-biotech segment.
ビジネスモデルの特徴
The company depends on translational science, platform validation, and the ability to keep a narrow pipeline funded while it develops its biology. Investors watch early data, strategic changes, and financing needs.
バイオ業界での位置付け
Surrozen occupies a specialized regenerative-biology niche within biotech. The stock is sensitive to whether its platform can move beyond concept toward clinical relevance.
今後のカタリスト
- Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance. The company is still early and data-dependent.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。